The N-myc oncogene in human neuroblastoma cells: Down-regulation of an angiogenesis inhibitor identified as activin A

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4596-4601

  Breit, Stephen ^a   Ashman, Keith ^b   Wilting, Jörg ^c   Rössler, Jochen ^a   Hatzi, Elissavet ^d   Fotsis, Theodore ^d   Schweigerer, Lothar ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

EID: 0034662610     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Blood vessel formation: What is its molecular basis?
2. Fibroblast growth factor
3. The biology of vascular endothelial growth factor
4. Signaling vascular morphogenesis and maintenance
5. Antiangiogenesis as a novel therapeutic concept in pediatric oncology
6. Pattern formation during animal development
7. Similarities between embryonic and neoplastic systems
8. Molecular mechanisms of developmental and tumor angiogenesis
9. Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia
10. Overview. Biology of neuroblastoma
11. Molecular cytogenetics of human neuroblastoma
12. The N-myc proto-oncogene: Developmental expression and in vivo site-directed mutagenesis
13. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes
14. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus
15. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth activity
16. Tumor angiogenesis correlates with metastatic disease. N-myc amplification, and poor outcome in human neuroblastoma
17. Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells
18. Human activin βA gene: Identification of novel 5′ exon, functional promoter, and enhancers
19. Localization of regulatory elements controlling human MYCN expression
20. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
21. Suppression of MYC by high expression of NMYC in human neuroblastoma cells
22. The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth
23. Cleavage of structural proteins during assembly of the head of Bacteriophage T4
24. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity
25. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
26. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells
27. Concentrating nucleic acids: Precipitation with ethanol or isopropanol
28. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
29. Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo
30. The N-myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells
31. Angiogenesis and angiogenesis inhibition: An overview
32. Tumor angiogenesis
33. The inhibin/activin family of hormones and growth factors
34. Activins and activin receptors in cell growth
35. Roles of inhibins, activins, and follistatin in the female reproductive system
36. Inhibition of vascular endothelial cell growth by activin-A
37. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo
38. Structure and sequence analysis of the human activin β A subunit gene
39. Transforming growth factor-β: Vasculogenesis, angiogenesis, and vessel wall integrity
40. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily
41. Activins and the receptor serine kinase superfamily
42. Molecular defects in rare bleeding disorders: Hereditary haemorrhagic telangiectasia
43. Integrin-dependent adhesive activity is spatially controlled by inductive signals at gastrulation
44. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins
45. How tumors become angiogenic